Bromantane administration in therapeutic doses is characterised from the Nearly entire absence of Unwanted effects together with manifestations of withdrawal syndrome and hyperstimulation (Morozov et al The 2018 research by Wang et al. investigated the results of angiotensin IV on inflammation in